Investor Presentaiton
Q3 FINANCIAL UPDATE
REVENUE GROWTH Q3 YTD CY2016-CY2018
-
Calendar Year To Date
$A in 000s
Total Revenue
Y/Y Growth %
-
MBS/TB Revenue
Q3 2016
Q3 2017
Q3 2018
$2,250
$1,525
$2,121
-32%|
39%!
$1,248
$1,086
$1,801
Y/Y Growth - %
-13%
66%!
Recurring Revenue - %
55%
71%i
85%i
Contract Won
AARP
BOEING
neuroCare.
Nationwide
Nationwide
Total Contracted Revenue
Description
Value ($)
2-yr. Direct contract
$1,528
Expand to union workers (47k)
$230
4-yr. EEG software/data license
$150
New Screening product sale
$25
$1,933
Brain Resource®
CONTINUED GROWTH IN
PUBLIC KPIS DURING CY2018
39% Y/Y GROWTH IN TOTAL
REVENUE
YTD growth reverses negative trajectory
from prior period and achieved without the
redesigned MBS/TB platform or new
screening product sales
66% Y/Y GROWTH IN MBS/TB
REVENUE
Fueling strategic shift in mix towards
recurring SaaS revenue (85% of total)
PRE-TOTAL BRAIN LAUNCH
MARKET VALIDATION
4 major contracts won ahead of company
and product revamp
Note: American Association of Retired Persons ("AARP") contract with minimum of A$675k and maximum of A$6M over 2 years. Contractual maximum based on
usage tiers and assumes full penetration of AARP's 38mm member base. A$1.5M base case assumes BRC attains 500k users over 2 years. For reference, there
were 200k new users from AARP during 2017 via their legacy product and with less marketing support for BRC's solution.
18
©2018 BRAIN RESOURCE LTD. - CONFIDENTIAL MATERIAL ALL RIGHTS RESERVEDView entire presentation